Yan Yu

3.9k total citations
73 papers, 2.8k citations indexed

About

Yan Yu is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Yan Yu has authored 73 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 17 papers in Epidemiology and 16 papers in Immunology. Recurrent topics in Yan Yu's work include Immune Response and Inflammation (10 papers), MicroRNA in disease regulation (9 papers) and RNA modifications and cancer (8 papers). Yan Yu is often cited by papers focused on Immune Response and Inflammation (10 papers), MicroRNA in disease regulation (9 papers) and RNA modifications and cancer (8 papers). Yan Yu collaborates with scholars based in China, United States and Malaysia. Yan Yu's co-authors include Daolin Tang, Zhi-yong Sheng, Min Xie, Xiaolong Chen, Guangying Cui, Ranran Sun, Ning Dong, Philip Vernon, Rui Kang and Fang Ren and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Yan Yu

73 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Yu China 30 1.5k 863 674 382 350 73 2.8k
Quancheng Kan China 35 2.5k 1.6× 1.2k 1.4× 584 0.9× 270 0.7× 515 1.5× 118 4.0k
Madhu Khullar India 32 1.2k 0.8× 427 0.5× 343 0.5× 212 0.6× 233 0.7× 146 3.2k
Minghua Yang China 29 2.3k 1.5× 1.2k 1.3× 737 1.1× 749 2.0× 357 1.0× 95 4.0k
Tanveer Ahmad India 32 1.6k 1.1× 530 0.6× 356 0.5× 501 1.3× 203 0.6× 66 3.4k
Li Jiao United States 37 1.3k 0.9× 607 0.7× 598 0.9× 170 0.4× 1.3k 3.8× 116 3.7k
Qiang He China 27 1.0k 0.7× 363 0.4× 474 0.7× 212 0.6× 122 0.3× 179 2.8k
Hiroko Shimizu Japan 30 1.5k 1.0× 410 0.5× 319 0.5× 444 1.2× 448 1.3× 99 2.8k
Xin Chen China 32 1.4k 0.9× 905 1.0× 258 0.4× 541 1.4× 267 0.8× 180 3.7k
Hao Wu China 30 1.2k 0.8× 331 0.4× 232 0.3× 669 1.8× 161 0.5× 155 2.9k
Zhi Zeng China 31 1.6k 1.0× 632 0.7× 359 0.5× 377 1.0× 475 1.4× 127 3.5k

Countries citing papers authored by Yan Yu

Since Specialization
Citations

This map shows the geographic impact of Yan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Yu more than expected).

Fields of papers citing papers by Yan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Yu. The network helps show where Yan Yu may publish in the future.

Co-authorship network of co-authors of Yan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Yu. A scholar is included among the top collaborators of Yan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Yu. Yan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Yuanhua, Quynh‐Thu Le, Weiguang Lv, et al.. (2025). Ultrafast and ultrastable Na-ion storage in interface engineered MoS2/MXene nanohybrids with nanoconfinement for high-performance sodium-ion capacitors. Chemical Engineering Journal. 505. 159268–159268. 12 indexed citations
2.
Zhou, Haixia, Xiaofeng Zhou, Sijia Li, et al.. (2025). Gracillin suppresses cancer progression through inducing Merlin/LATS protein-protein interaction and activating Hippo signaling pathway. Acta Pharmacologica Sinica. 46(7). 2016–2028. 1 indexed citations
4.
Yu, Yan, Dan Zhao, Rui Li, et al.. (2020). E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway. Cell Death and Disease. 11(4). 273–273. 53 indexed citations
5.
Yu, Shibo, Lizhe Zhu, Ke Wang, et al.. (2019). Green tea consumption and risk of breast cancer. Medicine. 98(27). e16147–e16147. 26 indexed citations
6.
Li, Jianhao, et al.. (2019). The Role of Upregulated DDX11 as A Potential Prognostic and Diagnostic Biomarker in Lung Adenocarcinoma. Journal of Cancer. 10(18). 4208–4216. 31 indexed citations
7.
He, Yuting, Chen Xue, Yan Yu, et al.. (2018). CD44 is overexpressed and correlated with tumor progression in gallbladder cancer. Cancer Management and Research. Volume 10. 3857–3865. 45 indexed citations
8.
Bao, Jie, Yan Yu, Jianan Chen, et al.. (2018). MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway. Cell Death and Disease. 9(10). 1045–1045. 72 indexed citations
9.
Zhao, Mingyi, Yan Yu, Min Xie, et al.. (2016). Digital gene expression profiling analysis of childhood acute lymphoblastic leukemia. Molecular Medicine Reports. 13(5). 4321–4328. 4 indexed citations
10.
Yang, Minghua, Liying Liu, Min Xie, et al.. (2015). Poly-ADP-ribosylation of HMGB1 regulates TNFSF10/TRAIL resistance through autophagy. Autophagy. 11(2). 214–224. 57 indexed citations
11.
Yu, Yan, Jingyu Yang, Yanhua Mou, et al.. (2010). Possible Metabolic Pathways of Ethanol Responsible for Oxidative DNA Damage in Human Peripheral Lymphocytes. Alcoholism Clinical and Experimental Research. 35(1). 1–9. 132 indexed citations
12.
Yang, Minghua, R Kang, Zhenyu Wang, et al.. (2010). HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia. 25(1). 23–31. 215 indexed citations
13.
Huang, Lifeng, Yong-Ming Yao, Ning Dong, et al.. (2010). Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study. Critical Care. 14(1). R3–R3. 75 indexed citations
14.
Ye, Feng, et al.. (2009). Evaluation of immune inhibitory cytokine profiles in epithelial ovarian carcinoma. Journal of obstetrics and gynaecology research. 35(2). 212–218. 29 indexed citations
15.
Yao, Yong-ming, Yan Yu, Jiake Chai, et al.. (2007). EFFECTS OF CD14-159 C/T POLYMORPHISM ON CD14 EXPRESSION AND THE BALANCE BETWEEN PROINFLAMMATORY AND ANTI-INFLAMMATORY CYTOKINES IN WHOLE BLOOD CULTURE. Shock. 28(2). 148–153. 30 indexed citations
16.
Yao, Yong-Ming, et al.. (2004). Tissue lipopolysaccharide-binding protein expression in rats after thermal injury: potential role of TNF-α. Burns. 30(3). 225–231. 13 indexed citations
17.
Yu, Yan, et al.. (2002). Glucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian Malays. Human Mutation. 21(1). 101–101. 88 indexed citations
18.
Yao, Yong-ming, Yan Yu, Huaping Liang, et al.. (1997). Influence of Selective Decontamination of the Digestive Tract on Cell-mediated Immune Function and Bacteria/Endotoxin Translocation in Thermally Injured Rats. PubMed. 42(6). 1073–1079. 30 indexed citations
20.
Yao, Yong-Ming, et al.. (1996). Elevated serum neopterin level: its relation to endotoxaemia and sepsis in patients with major burns. European Journal of Clinical Investigation. 26(3). 224–230. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026